As climate-related disasters become more frequent, understanding their social and economic impact is crucial. This Census Bureau working paper explores how household income, demographic factors, and geography influence the ability…
Learn MoreThe FY 2026 Budget in Brief outlines strategic investments to strengthen U.S. national security, bolster public health, and advance innovation across sectors. Key funding priorities include climate resilience, modernizing infrastructure,…
Learn MoreThe 2025 National Drug Threat Assessment reveals a stark picture of the evolving drug landscape in the U.S., driven by synthetic opioids like fentanyl and methamphetamine. Mexican cartels, now designated…
Learn MoreDespite growing calls from across the political spectrum to impose price controls on prescription drugs, this report argues that many common criticisms of the pharmaceutical industry don’t align with the…
Learn MoreOver the past two decades, the U.S. has experienced a profound demographic shift: the population of adults aged 65 and older is now nearly equal to the number of children.…
Learn MoreThe aging population is reshaping the demographic landscape of the United States. As of 2024, older adults now outnumber children in nearly half of U.S. counties—a reflection of long-term trends…
Learn MoreAugmented and virtual reality (AR/VR) technologies are rapidly redefining health care—from personalized surgical planning and chronic pain relief to mental health treatment and medical education. This report outlines how immersive…
Learn MoreAs viruses continue to mutate, traditional vaccines must be frequently updated—sometimes annually. Universal vaccines aim to break that cycle by offering longer-lasting protection against multiple or all strains of a…
Learn MoreDespite growing calls from across the political spectrum to impose price controls on prescription drugs, this report argues that many common criticisms of the pharmaceutical industry don’t align with the…
Learn MoreA new executive order takes decisive steps to improve the safety and oversight of biological research, especially dangerous gain-of-function experiments. It halts U.S. funding for risky research conducted abroad in…
Learn MoreThis executive order aims to eliminate regulatory roadblocks that slow the domestic production of critical medicines. It directs multiple federal agencies—including the FDA, EPA, and Army Corps of Engineers—to streamline…
Learn MoreThis executive order establishes the National Center for Warrior Independence to provide housing, care, and support services for homeless veterans, starting with a major redevelopment of the West Los Angeles…
Learn MoreThis executive order aims to bring fairness to prescription drug pricing by ensuring Americans pay no more than patients in other developed nations. It directs federal agencies to push for…
Learn MoreThis executive order renews a comprehensive campaign to lower prescription drug prices by prioritizing patient access, transparency, and market competition. It directs federal agencies to reform Medicare drug negotiations, stabilize…
Learn MoreAs the healthcare landscape shifts, securing diverse funding is essential to sustain primary care research. This resource offers guidance on tapping into federal agencies, foundations, healthcare systems, and even private…
Learn More